Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul;30(4):e2101.
doi: 10.1002/rmv.2101. Epub 2020 Feb 26.

Dengue: Status of current and under-development vaccines

Marianna Redoni  1 , Sophie Yacoub  2   3 , Laura Rivino  4 , Daniele Roberto Giacobbe  5 , Roberto Luzzati  1 , Stefano Di Bella  1
Affiliations
Free article
Review

Dengue: Status of current and under-development vaccines

Marianna Redoni et al. Rev Med Virol. 2020 Jul.
Free article

Abstract

Dengue is an emerging mosquito-borne viral infection with increasing reports of outbreaks. The clinical picture ranges from a benign febrile illness through to severe and potentially fatal manifestations. No specific anti-viral treatment exists, and therapy only consists of supportive care. During the last three decades, several attempts to develop an effective vaccine have been made. The first dengue vaccine to obtain licensure was Dengvaxia, which was authorized in 2015 and is currently available in over 20 countries. Its use has been approved with strict limitations regarding age and serostatus of the recipients, highlighting the necessity for a more safe and efficacious vaccine. At present several vaccine, candidates are undergoing clinical and pre-clinical trials. The most advanced candidates are TDV and TDV 003/005, two live-attenuated vaccines, but another 15 vaccines are under development, introducing novel immunization strategies to the traditional dengue vaccine scenario. This work reviews the current research status on dengue vaccines.

Keywords: dengue; vaccination; vaccine.

PubMed Disclaimer

References

REFERENCES

    1. https://www.who.int/emergencies/ten-threats-to-global-health-in-2019
    1. Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature. 2013;496:504-507.
    1. Na W, Yeom M, Choi IK, Yook H, Song D. Animal models for dengue vaccine development and testing. Clin Exp Vaccine Res. 2017;6:104-110.
    1. McArthur MA, Sztein MB, Edelman R. Dengue vaccines: recent developments, ongoing challenges and current candidates. Expert Rev Vaccines. 2013;12:933-953.
    1. Tsai WY, Lin HE, Wang WK. Complexity of human antibody response to dengue virus: implication for vaccine development. Front Microbiol. 2017;8:1372.